ANGOTZI, FRANCESCO

ANGOTZI, FRANCESCO  

Dipartimento di Medicina - DIMED  

Mostra records
Risultati 1 - 20 di 34 (tempo di esecuzione: 0.05 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
An Uncommon Localization of Hairy Cell Leukemia: Central Nervous System Involvement and Response to Ibrutinib—A Case Report and a Review of the Literature 2026 Cellini, AlessandroAngotzi, FrancescoTrimarco, ValentinaBriani, ChiaraPiazza, FrancescoTrentin, LivioVisentin, Andrea + AMERICAN JOURNAL OF HEMATOLOGY - -
Balancing safety and efficacy of Bendamustine plus anti CD20 regimens in elderly patients (> 70 y) with follicular lymphoma: a tertiary academic center experience 2026 Scapinello, GretaSerafin, AndreaAngotzi, FrancescoCellini, AlessandroVisentin, AndreaTrentin, LivioPiazza, Francesco + ANNALS OF HEMATOLOGY - -
Characteristics and Outcomes of Progressive Multifocal Leukoencephalopathy in Hematologic Malignancies: A SEIFEM Retrospective Review 2026 Angotzi, Francesco + AMERICAN JOURNAL OF HEMATOLOGY - -
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real‐World Study 2026 Visentin, AndreaMele, AnnaAngotzi, FrancescoTrentin, Livio + HEMATOLOGICAL ONCOLOGY - -
Disease course of FLT3 mutated extramedullary acute myeloid leukemia and efficacy of gilteritinib 2026 Angotzi, FrancescoVisentin, AndreaTrentin, Livio + HAEMATOLOGICA - -
Outcomes of patients with CLL and borderline IGHV mutational status: a systematic review and meta analysis 2026 Angotzi, FrancescoSerafin, AndreaCellini, AlessandroPagnin, ElisaFrezzato, FedericaFacco, MonicaPiazza, FrancescoTrentin, LivioVisentin, Andrea + BIOMARKER RESEARCH - -
Prognostic and predictive impact of NOTCH1 mutations in patients with chronic lymphocytic leukemia: a tertiary single-center experience 2026 Serafin, AndreaAngotzi, FrancescoCellini, AlessandroPiazza, FrancescoPiovan, ErichTrentin, LivioVisentin, Andrea + FRONTIERS IN ONCOLOGY - -
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian Cohort 2026 Visentin, AndreaAngotzi, FrancescoTrentin, Livio + BLOOD ADVANCES - -
Case Report: Triplet combination with pirtobrutinib/venetoclax/rituximab in accelerated phase of chronic lymphocytic leukemia 2025 Cellini, AlessandroAngotzi, FrancescoRuocco, ValeriaPizzi, MarcoTrentin, LivioVisentin, Andrea + FRONTIERS IN HEMATOLOGY - -
Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study 2025 Roncaglia, EleonoraGaffo, EnricoCalabretto, GiuliaFrezzato, FedericaRuocco, ValeriaOrsi, SilviaMerlo, RobertoCaregari, AlbertoGlogovitis, IliasCellini, AlessandroAngotzi, FrancescoTrentin, LivioVisentin, AndreaBortoluzzi, Stefania + JOURNAL OF HEMATOLOGY & ONCOLOGY - -
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study 2025 Visentin, AndreaGaffo, EnricoRoncaglia, EleonoraFrezzato, FedericaCalabretto, GiuliaRuocco, ValeriaOrsi, SilviaCellini, AlessandroAngotzi, FrancescoTrentin, LivioBortoluzzi, Stefania + LEUKEMIA - -
Extent of bone marrow infiltration predicts disease progression in asymptomatic Waldenström macroglobulinemia 2025 Scapinello, GretaCarraro, MarcoCellini, AlessandroAngotzi, FrancescoVianello, FabrizioManni, SabrinaPizzi, MarcoVisentin, AndreaTrentin, LivioPiazza, Francesco + DISCOVER ONCOLOGY - -
Familial Forms of Chronic Lymphocytic Leukemia Have a Worse Prognosis Than Sporadic Forms: an Italian Case-Control Study 2025 Visentin, AndreaAngotzi, Francesco + BLOOD ADVANCES - -
Incidence, prevention and management of severe infections in patients undergoing therapy for chronic lymphocytic leukemia 2025 Cellini, AlessandroAngotzi, FrancescoPiazza, FrancescoTrentin, LivioVisentin, Andrea + EXPERT REVIEW OF HEMATOLOGY - -
Management strategies for patients with chronic lymphocytic leukaemia harbouring complex karyotype 2025 Cellini, AlessandroAngotzi, FrancescoTrentin, LivioVisentin, Andrea + BRITISH JOURNAL OF HAEMATOLOGY - -
Real‐life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy‐cell leukemia: A multicenter Italian retrospective study (HCL‐PG03R) 2025 Visentin, AndreaAngotzi, FrancescoTrentin, Livio + HEMASPHERE - -
Serum soluble interleukin-2 receptor levels in hairy cell leukaemia as a marker of tumour burden with prognostic value and as a tool for disease monitoring 2025 Angotzi, FrancescoCellini, AlessandroTonini, AlessiaFrezzato, FedericaPizzi, MarcoTrentin, LivioVisentin, Andrea + BRITISH JOURNAL OF HAEMATOLOGY - -
Venetoclax and ibrutinib: Two partners for the front-line treatment of chronic lymphocytic leukemia 2025 Visentin, AndreaCellini, AlessandroAngotzi, Francesco + CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - -
Venetoclax based regimens in octogenarian CLL patients: efficacy, safety and comparison to BTKi in a multicenter cohort 2025 Cellini, AlessandroAngotzi, FrancescoTrentin, LivioVisentin, Andrea + BLOOD ADVANCES - -
Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD 2024 Angotzi, FrancescoPizzi, MarcoCrimi', FilippoPiazza, FrancescoTrentin, LivioVisentin, Andrea + FRONTIERS IN ONCOLOGY - -